1. Home
  2. TBPH vs PDM Comparison

TBPH vs PDM Comparison

Compare TBPH & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.73

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Logo Piedmont Office Realty Trust Inc.

PDM

Piedmont Office Realty Trust Inc.

HOLD

Current Price

$8.43

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
PDM
Founded
2013
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
993.7M
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TBPH
PDM
Price
$18.73
$8.43
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$27.80
$9.25
AVG Volume (30 Days)
601.0K
670.7K
Earning Date
11-10-2025
10-27-2025
Dividend Yield
N/A
1.47%
EPS Growth
N/A
N/A
EPS
0.58
N/A
Revenue
$80,327,000.00
$565,372,000.00
Revenue This Year
$70.78
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.19
N/A
Revenue Growth
27.12
N/A
52 Week Low
$7.90
$5.46
52 Week High
$20.33
$9.55

Technical Indicators

Market Signals
Indicator
TBPH
PDM
Relative Strength Index (RSI) 58.73 50.96
Support Level $18.39 $8.52
Resistance Level $20.32 $8.85
Average True Range (ATR) 0.87 0.28
MACD -0.05 0.04
Stochastic Oscillator 53.71 53.54

Price Performance

Historical Comparison
TBPH
PDM

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About PDM Piedmont Office Realty Trust Inc.

Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.

Share on Social Networks: